| Date & Time | 8 April 2026 12:00-13:00 CET |
|---|---|
| Address | Online |
Please save the date for Bridging Nordic ATMP, this season of ATMP Webinar Series hosted by the Nordic EATRIS Nodes (Sweden, Norway and Finland). The series will take place online, 12.00-13.00 CET, once a month with a lecture by an expert in the Advanced Therapy Medicinal Products (ATMPs) field. The next edition will feature the following speaker:
Marit Inngjerdingen, Dept of Pharmacology, University of Oslo, Norway will speak on Next Generation Therapies: Extracellular Vesicles from Natural Killer Cells
Marit Inngjerdingen is a professor in pharmacology at the Faculty of Medicine, University of Oslo, heading the Innate Lymphocyte Group and also serving as the head of the Department of Pharmacology. Her research centres on Natural Killer (NK) cells and their extracellular vesicles (EVs), exploring how NK cell–derived EVs can be harnessed as targeted nanovehicles to kill cancer cells, particularly in solid tumours where cellular infiltration is limited. Her group combines basic mechanistic studies with translational innovation projects aimed at therapeutic development and commercialisation of NK-cell derived nanovesicles. She has been awarded competitive funding, including a prestigious FRIPRO grant from the Research Council of Norway. At the national level, she is president of the Norwegian Society for Extracellular Vesicles (NOR-EV), where she promotes EV research, networking, and innovation across basic and clinical disciplines.
Register for the webinar here.
Remember to save the dates and look out for updates on each webinar before the start of the event. The next webinar will take place on March 4th.
The previous events took place on:
- 5 February 2025 – Magnus Essand, Professor of Gene Therapy, Uppsala University, Chief Scientific Officer and co-founder, Elicera Therapeutics
- 12 March 2025 – David Morrow, EATRIS Senior Scientific Programme Manager
- 2 April 2025 – Seppo Ylä-Herttuala, Professor at the University of Eastern Finland
- 7 May 2025 – Kamal Mustafa, Professor at the University of Bergen
- 4 June 2025 – Marie Gårdmark, Co-founder of RegSmart Life Science AB and Anna Pasetto, Director of the Centre for Advanced Cell Therapy (ACT) at Oslo University Hospital
- 3 September 2025 – Janet Hoogstraate, Chief Executive Officer at NorthX Biologics
- 1 October 2025 – Joel Clinton Glover, Director of Norwegian Core Facility for Human Pluripotent Stem Cells at the University of Oslo and Oslo University Hospital.
- 3 November 2025 – Özcan Met, Associate Professor and Head of Cell Therapy Unit, at CCIT-DK and DTU HealthTech
- 3 December 2025 – Erja Kerkelä, Development Manager, Docent (Associate Professor) at the Advanced Cell Therapy Centre, Finnish Red Cross Blood Service.
- 4 February 2026 – Emanuela Oldoni, Scientific Lead Personalised Medicine at EATRIS
- 4 March 2026 – Bjarne Kuno Møller, Dept. of Clinical Immunology, Aarhus University
